找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Urticaria and Angioedema; Torsten Zuberbier,Clive Grattan,Marcus Maurer Book 2021Latest edition Springer Nature Switzerland AG 2021 Dermat

[復制鏈接]
樓主: 粗略
31#
發(fā)表于 2025-3-26 21:52:37 | 只看該作者
Omalizumab in the Treatment of Urticaria,vere asthma since 2003, for adults and adolescents with chronic spontaneous urticaria unresponsive to antihistamines since 2014. The evidence base for its efficacy and safety in chronic urticaria is strong. Its introduction has changed the outlook for patients with chronic spontaneous urticaria not
32#
發(fā)表于 2025-3-27 03:50:48 | 只看該作者
Other Interventions for Chronic Urticaria,malizumab, approved for chronic spontaneous urticaria in 2014. Other interventions with low evidence have been used by specialists for decades to manage patients who do not respond to H1 antihistamines. Pharmacological interventions include oral corticosteroids, H2 antihistamines, anti-leukotrienes,
33#
發(fā)表于 2025-3-27 08:36:14 | 只看該作者
34#
發(fā)表于 2025-3-27 10:18:10 | 只看該作者
Urticaria Therapy and Management. Looking Forward,nt pathogenic and therapeutic advances in urticaria represent an extremely and desired benefit for CU patients and imply recognized improvement in the quality of CU management. The rationale of the new treatments shows therapeutic targets acting through different mechanisms involved in the wheal pat
35#
發(fā)表于 2025-3-27 15:13:24 | 只看該作者
36#
發(fā)表于 2025-3-27 20:34:41 | 只看該作者
37#
發(fā)表于 2025-3-27 23:40:27 | 只看該作者
Classification and Diagnosis of Urticaria,hey are inducible. Disease activity and level of symptoms must also be considered when assessing the severity of urticaria, and for this the UAS7 patient self-assessment is used. Acute, chronic, and spontaneous chronic urticaria also differ in the diagnostic work up.
38#
發(fā)表于 2025-3-28 02:08:16 | 只看該作者
Management Principles in Urticaria,c treatment using pharmacological agents is however often the only practical approach and comprises non-sedating antihistamines as first-line, their updosing as second-line and add-on of other agents as third- and fourth-line treatment options.
39#
發(fā)表于 2025-3-28 08:51:27 | 只看該作者
40#
發(fā)表于 2025-3-28 13:41:37 | 只看該作者
Impact of Chronic Urticaria and How to Measure It,ity scores and quality of life questionnaires provide important insights from the patient perspective. The urticaria and angioedema control tests help to distinguish well-controlled from poorly controlled disease and to determine the need for treatment adjustments. The clinical pattern of chronic in
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 18:48
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
霍州市| 石狮市| 汉沽区| 图们市| 昭觉县| 西峡县| 景德镇市| 钟祥市| 荃湾区| 松溪县| 崇礼县| 文成县| 新密市| 德格县| 天峨县| 罗源县| 清流县| 新河县| 库尔勒市| 迭部县| 泸水县| 夏津县| 上林县| 清远市| 沂水县| 诏安县| 华宁县| 临清市| 留坝县| 卢氏县| 睢宁县| 灵丘县| 汝阳县| 永善县| 固安县| 获嘉县| 绵阳市| 鄂托克旗| 新丰县| 宁晋县| 黄浦区|